• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • The EveryLife Foundation for Rare Diseases, Washington, DC

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

The Total Economic Impact of Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers in the United States

Author:Osborne, Benjamin   Bernitsas, Evanthia   Rebeira, Mayvis   Betor, Nicole   Dodd, Caitlin   Loreto, Jesus   Olsen, Ashlee   Garduno, Alexis   Lee, Justin   Przybyl, Lindsey   Sullivan, Jamie   Yu, Jeffrey   

Session Name:P7: Autoimmune Neurology: NMOSD and MOGAD 1  

Topic:Autoimmune Neurology  

Program Number:P7.008  

Author Institution:Medstar Georgetown University Medical Center, Washington, DC  Creighton University, Omaha, NE  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Avalere, Washington, DC  Patient Consultant, Orlando, FL  Alexion, AstraZeneca Rare Disease, Boston, MA  The EveryLife Foundation for Rare Diseases, Washington, DC  

  • View Abstract
  • View Disclosure

Evaluation of the Indirect and Nonmedical Impacts of Generalized Myasthenia Gravis on Patients and Caregivers

Author:Gwathmey, Kelly   Yee, Karen   Foss, Allison   Ramirez, Christina   Sullivan, Jamie   dosReis, Susan   Thiele, Craig   Schwartz, Taylor   Betor, Nicole   Hunt, Olivia   Rebeira, Mayvis   Narayanaswami, Pushpa   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.032  

Author Institution:VCU Health, Richmond, VA  Alexion, AstraZeneca Rare Disease, Boston, MA  Myasthenia Gravis Association, Kansas City, MO  Patient Consultant, Rogers, AR  The EveryLife Foundation for Rare Diseases, Washington, DC  University of Maryland School of Pharmacy, Baltimore, MD  Health Management Associates (subcontractor), Dayton, OH  Avalere, Washington, DC  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com